About Tasso
Tasso is a company based in Seattle (United States) founded in 2014. Tasso has raised $123.22 million across 7 funding rounds from investors including SVB, Cedars Sinai and D. E. Shaw Group. The company has 1 employees as of September 30, 2024. Tasso offers products and services including Tasso+, Tasso Mini, Tasso-M20, and Tasso Kits. Tasso operates in a competitive market with competitors including Babson Diagnostics, YourBio Health, Weavr Health, Velano Vascular and Lo Biosciences, among others.
- Headquarter Seattle, United States
- Employees 1 as on 30 Sep, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tasso Oü
-
Annual Revenue
$20.31 K (USD)60as on Dec 31, 2023
-
Net Profit
$767.45 (USD)-30as on Dec 31, 2023
-
EBITDA
Not available
-
Total Equity Funding
$123.22 M (USD)
in 7 rounds
-
Latest Funding Round
$100 M (USD), Series B
Dec 16, 2021
-
Investors
SVB
& 13 more
-
Employee Count
1
as on Sep 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tasso
Tasso offers a comprehensive portfolio of products and services, including Tasso+, Tasso Mini, Tasso-M20, and Tasso Kits.
Lancet for collecting whole liquid blood samples painlessly.
Compact tool for frequent or sensitive blood sampling.
Device for various blood collection applications.
Comprehensive kits for international blood sample processing.
People of Tasso
Unlock access to complete
Unlock access to complete
Funding Insights of Tasso
Tasso has successfully raised a total of $123.22M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $100 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tasso
Tasso has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Cedars Sinai and D. E. Shaw Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Locked | Locked | Locked | |
|
Investments in tech startups are made by J2 Ventures.
|
Locked | Locked | Locked |
Investor details for Tasso
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tasso
Investment portfolio details for Tasso
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tasso
Detailed financials for Tasso
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tasso Comparisons
Peer comparison for Tasso
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tasso
Tasso operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Babson Diagnostics, YourBio Health, Weavr Health, Velano Vascular and Lo Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Blood testing services are offered using finger-prick microsamples.
|
|
| Locked | Locked | Locked |
Push-button blood collection devices are manufactured for medical use.
|
|
| Locked | Locked | Locked |
Manufactures high-quality blood collection devices for medical applications.
|
|
| Locked | Locked | Locked |
Provider of a needle-free blood collection device
|
|
| Locked | Locked | Locked |
Developer of blood collection device
|
Detailed competitors of Tasso
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tasso
Complete news archive for Tasso
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tasso
Tasso was founded in 2014.
Tasso is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Tasso is a funded company, having raised a total of $123.22M across 7 funding rounds to date.
As of Sep 30, 2024, the latest employee count at Tasso is 1.
Annual revenue of Tasso is $20.31K as on Dec 31, 2023.
Tasso was founded in 2014 and is based in Seattle, United States. Operations focus on the medical device sector, where blood collection devices are developed for diagnostic uses. Products such as TASSO, TASSO-M20, and TASSO-SST are designed to collect whole liquid blood samples suitable for various downstream applications, including testing and analysis.
Tasso's top competitors include Babson Diagnostics, YourBio Health and Velano Vascular.
Tasso offers Tasso+, Tasso Mini, Tasso-M20, and Tasso Kits.
Tasso has 14 investors. Key investors include SVB, Cedars Sinai, D. E. Shaw Group, HHS, and Senvest Capital.